Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Pulmonary Hypertension, November 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 178 articles: HTML format

Single Articles

1. SEGOVIA F, Garcia H, Alkhateeb H, Mukherjee D, et al
   Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
   Cardiovasc Hematol Disord Drug Targets. 2023.
   PubMed    
   Abstract available
   
   

2. GUARINO D, Ballerini A, Manes A
   What changed after the 2022 guidelines for pulmonary hypertension?
   Eur J Intern Med. 2023 Oct 31:S0953-6205(23)00384.
   PubMed    
   
   
   

3. CHEN S, Lin S, Liu W, Lin Q, et al
   Serum Metabolomic Profile in Hypoxia-Induced Pulmonary Hypertension Mice after C75 Treatment.
   Front Biosci (Landmark Ed). 2023;28:251.
   PubMed    
   Abstract available
   
   

4. HELD M, Wilkens H
   [Pulmonary hypertension - The new ESC guideline].
   Dtsch Med Wochenschr. 2023;148:1448-1455.
   PubMed    
   Abstract available
   
   

5. CHEN YX, Deng ZH, Xue-Gao, Qiang-Du, et al
   Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
   Biomed Pharmacother. 2023;168:115816.
   PubMed    
   Abstract available
   
   

6. ROTHMAN A, Restrepo H, Evans WN, Sarukhanov V, et al
   CAR Selectively Enhances the Pulmonary Vasodilatory Effect of Fasudil in a Microsphere Model of Pulmonary Hypertension.
   Open Respir Med J. 2023;17:e187430642303160.
   PubMed    
   Abstract available
   
   

7. COLLACO JM, Abman SH, Austin ED, Avitabile CM, et al
   Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension.
   Pulm Circ. 2023;13:e12305.
   PubMed    
   Abstract available
   
   

8. ZENG C, Liu J, Zheng X, Hu X, et al
   Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
   Respir Res. 2023;24:263.
   PubMed    
   Abstract available
   
   

9. MARCHIORI E, Hochhegger B, Zanetti G
   Pulmonary hypertension.
   J Bras Pneumol. 2023;49:e20230275.
   PubMed    
   
   
   

10. EROL C
    Machine Learning, Pulmonary Hypertension....
    Anatol J Cardiol. 2023;27:615.
    PubMed    
    
    
    

11. RAJARATNAM A, El-Swais A, McTiernan C, Thoma FW, et al
    Persistence of pulmonary hypertension in patients undergoing ventricular assist devices and orthotopic heart transplantation.
    Pulm Circ. 2023;13:e12296.
    PubMed    
    Abstract available
    
    

12. MARINHO Y, Villarreal ES, Aboagye SY, Williams DL, et al
    Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
    Front Immunol. 2023;14:1254762.
    PubMed    
    Abstract available
    
    

13. JOHNG S, Fraga MV, Patel N, Kipfmueller F, et al
    Unique Cardiopulmonary Interactions in Congenital Diaphragmatic Hernia: Physiology and Therapeutic Implications.
    Neoreviews. 2023;24:e720-e732.
    PubMed    
    Abstract available
    
    

14. TOJAGA N, Egholm G, Lund Hansen D
    Clinical challenges in the treatment of a patient with decompensated heart failure and glucose-6-phosphate dehydrogenase deficiency (G6PDd).
    BMJ Case Rep. 2023;16:e255722.
    PubMed    
    Abstract available
    
    

15. SANDEEP B, Li H, Huang X, Xiao Z, et al
    An editorial regarding the article 'A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?'.
    Curr Probl Cardiol. 2023 Oct 29:102172. doi: 10.1016/j.cpcardiol.2023.102172.
    PubMed    
    Abstract available
    
    

16. CADOUR F, Sourdon J, Rapacchi S
    Editorial for "Biventricular Dysfunction and Ventricular Interdependence in Patients With Pulmonary Hypertension: A 3.0-T Cardiac MRI Feature Tracking Study".
    J Magn Reson Imaging. 2023 Oct 31. doi: 10.1002/jmri.29092.
    PubMed    
    
    
    

17. LANG IM, Delcroix M
    Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion.
    Hamostaseologie. 2023 Oct 30. doi: 10.1055/a-2173-7712.
    PubMed    
    Abstract available
    
    

18. BARBERA JA, Humbert M
    Monographic Issue on Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023;44:719-720.
    PubMed    
    
    
    

19. QIN J, Wang G, Han D
    Benefits of Macitentan in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Glob Heart. 2023;18:58.
    PubMed    
    Abstract available
    
    

20. TOMASINO M, Soriano Colome T, Sambola Ayala A, Gordon Ramirez B, et al
    Acute pulmonary artery dissection in an adult with chronic pulmonary hypertension secondary to congenital heart disease: a case report.
    Eur Heart J Case Rep. 2023;7:ytad508.
    PubMed    
    Abstract available
    
    

21. LIU X, Zhou H, Zhang H, Jin H, et al
    Advances in the research of sulfur dioxide and pulmonary hypertension.
    Front Pharmacol. 2023;14:1282403.
    PubMed    
    Abstract available
    
    

22. YU W, Zhang Q, Qiu Y, Chen H, et al
    CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
    Clin Exp Hypertens. 2023;45:2272062.
    PubMed    
    Abstract available
    
    

23. ROSE SW, Highland KB, Kelkar AA
    Clinical Utility of Patient-Reported Outcome Instruments in the Management of Pulmonary Hypertension: A Systematic Review.
    JACC Heart Fail. 2023 Oct 25:S2213-1779(23)00616.
    PubMed    
    Abstract available
    
    

24. ISHIYAMA M, Fujimoto N, Fukuoka S, Omori T, et al
    Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease.
    JACC Heart Fail. 2023 Oct 11:S2213-1779(23)00611.
    PubMed    
    
    
    

25. GALLEGO-ZAZO N, Miranda-Alcaraz L, Cruz-Utrilla A, Del Cerro Marin MJ, et al
    Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature.
    Genes (Basel). 2023;14:1965.
    PubMed    
    Abstract available
    
    

26. GUNAYDIN FE, Belen E, Altin S, Demir AU, et al
    Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey.
    Medicina (Kaunas). 2023;59:1869.
    PubMed    
    Abstract available
    
    

27. GOPALAN D, Riley JYJ, Leong K, Alsanjari S, et al
    Computed Tomography Pulmonary Angiography Prediction of Adverse Long-Term Outcomes in Chronic Thromboembolic Pulmonary Hypertension: Correlation with Hemodynamic Measurements Pre- and Post-Pulmonary Endarterectomy.
    Tomography. 2023;9:1787-1798.
    PubMed    
    Abstract available
    
    

28. GREDIC M, Hadzic S
    Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets.
    J Pers Med. 2023;13:1446.
    PubMed    
    Abstract available
    
    

29. REDDY R, Kalra SS, Alzghoul B, Khan A, et al
    Effect of Obesity on Mortality in Pulmonary Hypertension-A Systematic Review and Meta-Analysis.
    J Cardiovasc Dev Dis. 2023;10:419.
    PubMed    
    Abstract available
    
    

30. KIM JS, Jang JH, Jo DY, Ahn SY, et al
    Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
    J Korean Med Sci. 2023;38:e328.
    PubMed    
    Abstract available
    
    

31. AHMED A, Ahmed S, Radegran G
    [Risk stratification in pulmonary arterial hypertension - implementation of an internet-based risk calculator to guide treatment].
    Lakartidningen. 2023;120:23075.
    PubMed    
    Abstract available
    
    

32. SZAFRANSKI P, Garimella RP, Mani H, Hartman R, et al
    Further refinement of the differentially methylated distant lung-specific FOXF1 enhancer in a neonate with alveolar capillary dysplasia.
    Clin Epigenetics. 2023;15:169.
    PubMed    
    Abstract available
    
    

33. XI J, Ma Y, Liu D, Li R, et al
    Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1alpha signaling pathway.
    BMC Pulm Med. 2023;23:386.
    PubMed    
    Abstract available
    
    

34. KAMINSKY DA, Hibbert KA, Luks AM
    Review of Pulmonary Physiology.
    Semin Respir Crit Care Med. 2023;44:509-510.
    PubMed    
    
    
    

35. RAZA F, Chesler NC
    Distensibility, an Early Disease Marker of Pulmonary Vascular Health: Ready for Clinical Application.
    J Am Heart Assoc. 2023;12:e031605.
    PubMed    
    
    
    

36. ELLIOTT J, Menakuru N, Martin KJ, Rahaghi FN, et al
    iCPET Calculator: A Web-Based Application to Standardize the Calculation of Alpha Distensibility in Patients With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e029667.
    PubMed    
    Abstract available
    
    

37. ZHANG N, Qiu Q, Chen Y, Sun Z, et al
    [Quercetin improves pulmonary arterial hypertension in rats by regulating the HMGB1/RAGE/NF-kappaB pathway].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1606-1612.
    PubMed    
    Abstract available
    
    

38. KOBAK L, Abrahamovych O, Abrahamovych U, Maksymuk A, et al
    DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    Georgian Med News. 2023;.
    PubMed    
    Abstract available
    
    

39. QIAN AM, Cheng R, Gu XY, Yin R, et al
    [Treatment of patent ductus arteriosus in very preterm infants in China].
    Zhonghua Er Ke Za Zhi. 2023;61:896-901.
    PubMed    
    Abstract available
    
    

40. VALLE LRD, Martins CN, Lopes RM, Fantini FA, et al
    Reversed Potts Shunt as a Palliative Option for EndStage Idiopathic Pulmonary Arterial Hypertension in Childhood.
    Braz J Cardiovasc Surg. 2023;38:e20220034.
    PubMed    
    
    
    

41. MCCONNELL J, Bilir SP, Xu Y, Tsang Y, et al
    Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension.
    J Med Econ. 2023;26:1349-1355.
    PubMed    
    Abstract available
    
    

42. MUTGAN AC, Jandl K, Radic N, Valzano F, et al
    Pentastatin, a matrikine of the collagen IValpha5, is a novel endogenous mediator of pulmonary endothelial dysfunction.
    Am J Physiol Cell Physiol. 2023;325:C1294-C1312.
    PubMed    
    Abstract available
    
    

43. PEPLINSKI BS, Buber J, Gharib SA, Pi H, et al
    Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2023;20:1676-1679.
    PubMed    
    
    
    

44. SZAFRON JM, Yang W, Feinstein JA, Rabinovitch M, et al
    A computational growth and remodeling framework for adaptive and maladaptive pulmonary arterial hemodynamics.
    Biomech Model Mechanobiol. 2023;22:1935-1951.
    PubMed    
    Abstract available
    
    

45. LJUBOJEVIC-HOLZER S, Crnkovic S
    Boosting the Exhausted Vasculature-SIRT3 (to the) Rescue.
    Am J Respir Cell Mol Biol. 2023;69:497-499.
    PubMed    
    
    
    

46. MILLER CE, Franco V, Smith JS, Balasubramanian V, et al
    Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
    Respir Med. 2023;218:107374.
    PubMed    
    Abstract available
    
    

47. JENKINS DP, Martinez G, Salaunkey K, Reddy SA, et al
    Perioperative Management in Pulmonary Endarterectomy.
    Semin Respir Crit Care Med. 2023;44:851-865.
    PubMed    
    Abstract available
    
    

48. ALI HJ, Sahay S
    End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities.
    Semin Respir Crit Care Med. 2023;44:866-876.
    PubMed    
    Abstract available
    
    

49. BAO ZY, Li HM, Zhang SB, Fei YQ, et al
    Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis.
    Acta Pharmacol Sin. 2023;44:2201-2215.
    PubMed    
    Abstract available
    
    

50. GARNET B, Diaz-Lankenau R, Jean E, Campos M, et al
    Accuracy of Pulse Oximetry for Long-Term Oxygen Therapy Assessment in Chronic Obstructive Pulmonary Disease.
    Ann Am Thorac Soc. 2023;20:1587-1594.
    PubMed    
    Abstract available
    
    

51. WEATHERALD J, Varughese RA, Liu J, Humbert M, et al
    Management of Pulmonary Arterial Hypertension.
    Semin Respir Crit Care Med. 2023;44:746-761.
    PubMed    
    Abstract available
    
    

52. SPEROTTO F, Gearhart A, Hoskote A, Alexander PMA, et al
    Cardiac arrest and cardiopulmonary resuscitation in pediatric patients with cardiac disease: a narrative review.
    Eur J Pediatr. 2023;182:4289-4308.
    PubMed    
    Abstract available
    
    

53. BLETTE BS, Moutchia J, Al-Naamani N, Ventetuolo CE, et al
    Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials.
    Lancet Respir Med. 2023;11:873-882.
    PubMed    
    Abstract available
    
    

54. XU Z, Dou R, Zhou Z, Zhang H, et al
    Differential biventricular adaption to pulmonary vascular disease in patients with idiopathic/heritable and congenital heart disease: a prospective cardiac magnetic resonance and invasive study.
    Eur Heart J Cardiovasc Imaging. 2023;24:1528-1535.
    PubMed    
    Abstract available
    
    

55. TAKATSUKI S, Shimokawahara H, Shimizu Y, Kawai R, et al
    Clinical differences between children and adults with idiopathic and heritable pulmonary arterial hypertension.
    Cardiol Young. 2023;33:1909-1912.
    PubMed    
    Abstract available
    
    

56. CHOUBEY M, Kothari SS, Gupta SK, Ramakrishnan S, et al
    Pulmonary arterial compliance in patients of CHD with increased pulmonary blood flow.
    Cardiol Young. 2023;33:1889-1895.
    PubMed    
    Abstract available
    
    

57. GE T, Yang Y, Zhao Y
    A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease.
    Perfusion. 2023;38:1697-1704.
    PubMed    
    Abstract available
    
    

58. LI M, Liu L, Liu C, Chen Z, et al
    Selexipag for the Treatment of Pediatric Pulmonary Hypertension: A Systematic Review.
    Clin Ther. 2023 Nov 7:S0149-2918(23)00391.
    PubMed    
    Abstract available
    
    

59. GALIE N, Palazzini M, Manes A
    Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds.
    Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093.
    PubMed    
    
    
    

60. PHAM AT, Oliveira AC, Albanna M, Alvarez-Castanon J, et al
    Non-Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2023 Nov 9. doi: 10.1161/ATVBAHA.123.320121.
    PubMed    
    Abstract available
    
    

61. CAIN MT, Schafer M, Ross LK, Ivy DD, et al
    4D-Flow MRI intracardiac flow analysis considering different subtypes of pulmonary hypertension.
    Pulm Circ. 2023;13:e12307.
    PubMed    
    Abstract available
    
    

62. QAISER KN, Almoushref A, Mehta AK, Alkhayyat M, et al
    Fluid loading during the hemodynamic evaluation of pulmonary hypertension: a cross-sectional study.
    Cardiovasc Diagn Ther. 2023;13:833-842.
    PubMed    
    Abstract available
    
    

63. CANGIALOSI P, Wojtaszek E, Omar A, Gopalan R, et al
    Riociguat for the treatment of pulmonary hypertension in patients with end stage renal disease.
    Respir Med. 2023 Nov 6:107454. doi: 10.1016/j.rmed.2023.107454.
    PubMed    
    
    
    

64. XIN L, Zhang Y, Luo Q, Zhao Q, et al
    Development and validation of a nomogram for predicting hemodynamic response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Respir Med. 2023 Nov 6:107440. doi: 10.1016/j.rmed.2023.107440.
    PubMed    
    Abstract available
    
    

65. ALI HR, Thomas J, Sahay S, Guha A, et al
    Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor.
    Pulm Circ. 2023;13:e12303.
    PubMed    
    Abstract available
    
    

66. SATISH T, Chin K, Patel N
    Outcomes After Supraventricular Tachycardia Ablation in Patients With Group 1 Pulmonary Hypertension.
    Cardiol Res. 2023;14:403-408.
    PubMed    
    Abstract available
    
    

67. MISMETTI V, Delavenne X, Montani D, Bezzeghoud S, et al
    Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
    Respir Res. 2023;24:273.
    PubMed    
    Abstract available
    
    

68. HOPKINS CD, Wessel C, Chen O, El-Kersh K, et al
    Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension.
    Int J Biol Sci. 2023;19:5036-5054.
    PubMed    
    Abstract available
    
    

69. TYAGI S, Batra V, Gautam A
    Review of Advances on Management of Chronic Thromboembolic Pulmonary Hypertension.
    Int J Angiol. 2023;32:207-214.
    PubMed    
    Abstract available
    
    

70. ORJI R, Markson F, Ilelaboye A, Okoronkwo E, et al
    Pulmonary Hypertension Is Associated with Worse Outcomes in Patients Hospitalized for Sick Sinus Syndrome.
    J Innov Card Rhythm Manag. 2023;14:5622-5628.
    PubMed    
    Abstract available
    
    

71. ZHANG W, Hua Y, Zheng D, Chen Q, et al
    Expression and Clinical Significance of miR-8078 in Patients with Congenital Heart Disease-Associated Pulmonary Hypertension.
    Gene. 2023 Nov 3:147964. doi: 10.1016/j.gene.2023.147964.
    PubMed    
    Abstract available
    
    

72. YAN Q, Liu S, Sun Y, Chen C, et al
    Pyroptosis, apoptosis, necroptosis and endoplasmic reticulum stress in pulmonary hypertension.
    J Adv Res. 2023 Nov 3:S2090-1232(23)00321-1. doi: 10.1016/j.jare.2023.
    PubMed    
    Abstract available
    
    

73. RIBAS SOLA J, Sanchez-Corral Mena MA, Riera-Mestre A
    Update in the management of chronic thrombo-embolic pulmonary hypertension.
    Med Clin (Barc). 2023 Nov 2:S0025-7753(23)00545.
    PubMed    
    Abstract available
    
    

74. SANGES S, Sobanski V, Lamblin N, Hachulla E, et al
    Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
    Rev Med Interne. 2023 Nov 2:S0248-8663(23)01212.
    PubMed    
    Abstract available
    
    

75. GERTZ RJ, Gerhardt F, Pienn M, Lennartz S, et al
    Dual-layer dual-energy CT-derived pulmonary perfusion for the differentiation of acute pulmonary embolism and chronic thromboembolic pulmonary hypertension.
    Eur Radiol. 2023 Nov 3. doi: 10.1007/s00330-023-10337.
    PubMed    
    Abstract available
    
    

76. HAN Y, Guo Y, Duan L, Li T, et al
    Modified Transannular Patching Palliation versus Modified Blalock-Taussig-Thomas Shunt in Infants with Severe Tetralogy of Fallot with Diminutive Pulmonary Arteries.
    Heart Surg Forum. 2023;26:E512-E518.
    PubMed    
    Abstract available
    
    

77. EVRARD B, Woillard JB, Legras A, Bouaoud M, et al
    Diagnostic, prognostic and clinical value of left ventricular radial strain to identify paradoxical septal motion in ventilated patients with the acute respiratory distress syndrome: an observational prospective multicenter study.
    Crit Care. 2023;27:424.
    PubMed    
    Abstract available
    
    

78. WEI S, Lin L, Jiang W, Chen J, et al
    Naked cuticle homolog 1 prevents mouse pulmonary arterial hypertension via inhibition of Wnt/beta-catenin and oxidative stress.
    Aging (Albany NY). 2023;15:11114-11130.
    PubMed    
    Abstract available
    
    

79. WELCH CL, Aldred MA, Balachandar S, Dooijes D, et al
    Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
    Genet Med. 2023;25:100925.
    PubMed    
    Abstract available
    
    

80. ZHONG B, Tan K, Razak A, Sackett V, et al
    Early neurodevelopmental outcomes of extreme preterm infants exposed to paracetamol: a retrospective cohort study.
    Pediatr Res. 2023 May 17:1-6. doi: 10.1038/s41390-023-02649.
    PubMed    
    Abstract available
    
    

81. CHEN X, Quan R, Qian Y, Yang Z, et al
    10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
    Rheumatology (Oxford). 2023;62:3555-3564.
    PubMed    
    Abstract available
    
    

82. ALLWOOD BW, Joubert L, Janson J
    Chronic thromboembolic pulmonary hypertension: More options, more awareness.
    Afr J Thorac Crit Care Med. 2023;29.
    PubMed    
    
    
    

83. DAVIES-VAN ES SA, Pennel TC, Brink J, Symons GJ, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Cape Town, South Africa.
    Afr J Thorac Crit Care Med. 2023;29.
    PubMed    
    Abstract available
    
    

84. ALLWOOD BW, Manie S, Stolbrink M, Hunter L, et al
    Pulmonary hypertension in adults completing tuberculosis treatment.
    Afr J Thorac Crit Care Med. 2023;29.
    PubMed    
    Abstract available
    
    

85. WU C, Liu H, Ba M, Zha J, et al
    Angiotensin-converting enzyme - human amniotic mesenchymal stem cells improve pulmonary vascular remodeling in rats with pulmonary hypertension by promoting angiogenesis and counteracting inflammation.
    Int J Clin Exp Pathol. 2023;16:282-293.
    PubMed    
    Abstract available
    
    

86. SUMITOMO NF, Yamanoi K, Akiyama S, Kimura N, et al
    Successful Treatment of Pulmonary Artery Aneurysm With Atrioventricular Septal Defect and Pulmonary Hypertension: Clinical and Pathologic Features.
    CJC Pediatr Congenit Heart Dis. 2023;2:143-145.
    PubMed    
    
    
    

87. ZHONG Z, Li K, Shen C, Ma Y, et al
    Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue.
    Hum Cell. 2023 Nov 15. doi: 10.1007/s13577-023-01009.
    PubMed    
    Abstract available
    
    

88. YOUNIS M, Al-Antary N, Dalbah R, Qarajeh A, et al
    Echocardiography and Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Transplantation Evaluation.
    Am J Med Sci. 2023 Nov 13:S0002-9629(23)01405.
    PubMed    
    Abstract available
    
    

89. KAHF SA, Roche A, Baron A, Chantalat-Auger C, et al
    Pulmonary Hypertension in Sickle Cell Disease.
    Presse Med. 2023 Nov 13:104209. doi: 10.1016/j.lpm.2023.104209.
    PubMed    
    Abstract available
    
    

90. POCHEPNIA S, Lang IM, Milos RI, Rohrich S, et al
    Hughes-Stovin syndrome-An important differential diagnosis in patients with suspected chronic thromboembolic pulmonary hypertension : A case report.
    Wien Klin Wochenschr. 2023 Nov 15. doi: 10.1007/s00508-023-02299.
    PubMed    
    Abstract available
    
    

91. BRUGGER B, Aouad S, Geenens A, Kharat AM, et al
    [Home oxygen therapy].
    Rev Med Suisse. 2023;19:2153-2158.
    PubMed    
    Abstract available
    
    

92. GENECAND L, Firmann M, Gijs PJ, Lechartier B, et al
    [Pulmonary hypertension: how to differentiate rare from frequent etiologies?].
    Rev Med Suisse. 2023;19:2138-2145.
    PubMed    
    Abstract available
    
    

93. TYE SK, Razali NS, Ahmad Shauqi SA, Azeman NA, et al
    Perception towards palliative care among patients with pulmonary hypertension in malaysia: a correlation with disease status.
    Cardiol Young. 2023 Nov 15:1-6. doi: 10.1017/S1047951123003773.
    PubMed    
    Abstract available
    
    

94. MONTANI D, Antigny F, Jutant EM, Chaumais MC, et al
    Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
    ERJ Open Res. 2023;9:00350-2023.
    PubMed    
    Abstract available
    
    

95. WANG L, Huang J, Zhang R, Zhang M, et al
    Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-kappaB/HIF-1alpha/VEGF.
    iScience. 2023;26:108199.
    PubMed    
    Abstract available
    
    

96. FENG XL, Lu YB, Yang D, Xue Q, et al
    [Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:1188-1193.
    PubMed    
    Abstract available
    
    

97. CAIN MA, Lee J, Kuper S, Sinkey R, et al
    Two pregnancies in a patient following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    BMJ Case Rep. 2023;16:e256158.
    PubMed    
    Abstract available
    
    

98. KAEMMERER H, Diller GP, Dahnert I, Eichstaedt CA, et al
    [Pulmonary arterial hypertension in congenital heart disease - Part I].
    Pneumologie. 2023;77:956-961.
    PubMed    
    Abstract available
    
    

99. APITZ C, Kozlik-Feldmann R, Eichstaedt CA, Gorenflo M, et al
    [New aspects in pediatric pulmonary hypertension - Commented 2022ERS/ESC-PH guidelines].
    Pneumologie. 2023;77:947-955.
    PubMed    
    Abstract available
    
    

100. GUTH S, Wilkens H, Halank M, Held M, et al
     [Chronic thromboembolic pulmonary hypertension].
     Pneumologie. 2023;77:937-946.
     PubMed    
     Abstract available
     
     

101. SCHMIDT KH, Bikou O, Blindt R, Bruch L, et al
     [Pulmonary hypertension associated with left heart disease (group 2)].
     Pneumologie. 2023;77:926-936.
     PubMed    
     Abstract available
     
     

102. HALANK M, Zeder KE, Sommer N, Ulrich S, et al
     [Pulmonary hypertension associated with lung disease].
     Pneumologie. 2023;77:916-925.
     PubMed    
     Abstract available
     
     

103. LICHTBLAU M, Harutyunova S, Nechwatal R, Mayer L, et al
     [General measures and management of pulmonary arterial hypertension].
     Pneumologie. 2023;77:907-915.
     PubMed    
     Abstract available
     
     

104. GRUNIG E, Halank M, Neurohr C, Behr J, et al
     [Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider].
     Pneumologie. 2023;77:901-906.
     PubMed    
     Abstract available
     
     

105. KLOSE H, Harbaum L, Richter MJ, Lichtblau M, et al
     [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
     Pneumologie. 2023;77:890-900.
     PubMed    
     Abstract available
     
     

106. TELLO K, Richter MJ, Kremer N, Gall H, et al
     [Diagnostic Algorithm and Screening of Pulmonary Hypertension].
     Pneumologie. 2023;77:871-889.
     PubMed    
     Abstract available
     
     

107. EICHSTAEDT CA, Bikou O, Sommer N, Schermuly RT, et al
     [Genetic diagnostics and molecular approaches in pulmonary arterial hypertension].
     Pneumologie. 2023;77:862-870.
     PubMed    
     Abstract available
     
     

108. DOUSCHAN P, Egenlauf B, Gall H, Grunig E, et al
     [New definition and classification of pulmonary hypertension].
     Pneumologie. 2023;77:854-861.
     PubMed    
     Abstract available
     
     

109. GRUNIG E, Benjamin N, Behr J, Skowasch D, et al
     [The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference - A position paper of the German Society for Pneumology and Respiratory Medicine (DGP)].
     Pneumologie. 2023;77:852-853.
     PubMed    
     
     
     

110. STEPPAN J, Wang H, Nandakumar K, Poe A, et al
     LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
     bioRxiv. 2023 Oct 28:2023.10.24.563874. doi: 10.1101/2023.10.24.563874.
     PubMed    
     Abstract available
     
     

111. HOUSMAN B, Laskey D, Dawodu G, Scheinin S, et al
     Single Lung Transplant for Secondary Pulmonary Hypertension: The Right Option for the Right Patient.
     J Clin Med. 2023;12:6789.
     PubMed    
     Abstract available
     
     

112. BALSA A, Adao R, Bras-Silva C
     Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.
     Int J Mol Sci. 2023;24:15539.
     PubMed    
     Abstract available
     
     

113. LUI JK, Gillmeyer KR, Sangani RA, Smyth RJ, et al
     A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.
     Lung. 2023 Nov 13. doi: 10.1007/s00408-023-00646.
     PubMed    
     Abstract available
     
     

114. YU J, Huang S, Shen W, Zhang Z, et al
     Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients.
     Int J Chron Obstruct Pulmon Dis. 2023;18:2457-2471.
     PubMed    
     Abstract available
     
     

115. LV Z, Liang G, Cheng M
     Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
     Int J Chron Obstruct Pulmon Dis. 2023;18:2431-2438.
     PubMed    
     Abstract available
     
     

116. GRAFHAM GK, Bambrick M, Houbois C, Mafeld S, et al
     Enhancing preoperative assessment in chronic thromboembolic pulmonary hypertension: A comprehensive analysis of interobserver agreement and proximity-based CT pulmonary angiography scoring.
     Heliyon. 2023;9:e20899.
     PubMed    
     Abstract available
     
     

117. TAKAGI K, Kasai H, Tani H, Sakao S, et al
     Macitentan Administration for Pulmonary Hypertension Due to beta-thalassemia with Multiple Organ Failure: A Case Report.
     Intern Med. 2023 Nov 13. doi: 10.2169/internalmedicine.2307.
     PubMed    
     Abstract available
     
     

118. LIU Y, Wang H, Lan L, Shao J, et al
     A commentary regarding the article 'A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?'.
     Curr Probl Cardiol. 2023 Nov 10:102188. doi: 10.1016/j.cpcardiol.2023.102188.
     PubMed    
     Abstract available
     
     

119. HIROSE K, Minatsuki S, Saito A, Yagi H, et al
     Impact of psychiatric disorders on the hemodynamic and quality of life outcome of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study.
     Respir Res. 2023;24:274.
     PubMed    
     Abstract available
     
     

120. KITAHARA K, Omura J, Wada S, Kim SW, et al
     Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
     Pulm Ther. 2023 Nov 11. doi: 10.1007/s41030-023-00243.
     PubMed    
     Abstract available
     
     

121. ADAMEIT MSD, Wiedenroth CB, Omlor A, Schafers HJ, et al
     [Chronic thromboembolic pulmonary hypertension].
     Dtsch Med Wochenschr. 2023;148:1514-1523.
     PubMed    
     Abstract available
     
     

122. DAHER A, Klose H
     [Pathophysiology, diagnosis, prognosis and treatment of pulmonary hypertension associated with chronic lung disease].
     Dtsch Med Wochenschr. 2023;148:1507-1513.
     PubMed    
     Abstract available
     
     

123. WISSMULLER M, Tichelbacker T, Finke K, Dohr J, et al
     [Pulmonary hypertension associated with left heart disease (group 2)].
     Dtsch Med Wochenschr. 2023;148:1498-1506.
     PubMed    
     Abstract available
     
     

124. PIZARRO C, Nickenig G, Skowasch D
     [Diagnosis and therapy of pulmonary arterial hypertension].
     Dtsch Med Wochenschr. 2023;148:1491-1497.
     PubMed    
     Abstract available
     
     

125. EMON IM, Al-Qazazi R, Rauh MJ, Archer SL, et al
     The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases.
     Cells. 2023;12:2528.
     PubMed    
     Abstract available
     
     

126. LIU H, Wang Y, Zhang Q, Liu C, et al
     Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice.
     Immunol Lett. 2023;263:113-122.
     PubMed    
     Abstract available
     
     

127. REN H, Dai R, Nik Nabil WN, Xi Z, et al
     Unveiling the dual role of autophagy in vascular remodelling and its related diseases.
     Biomed Pharmacother. 2023;168:115643.
     PubMed    
     Abstract available
     
     

128. PIZZUTO MF, Laughon MM, Jackson WM
     Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants.
     Expert Opin Pharmacother. 2023;24:1875-1886.
     PubMed    
     Abstract available
     
     

129. AHMED MS, Ghallab M, Ostrow T, Nashawi M, et al
     Pharmacotherapy of refractory pulmonary arterial hypertension.
     Expert Opin Pharmacother. 2023;24:1861-1874.
     PubMed    
     Abstract available
     
     

130. ABDELHAFIZ A, Benscoter AL, Batlivala SP
     Spontaneous neonatal pulmonary arterial thrombosis - cases, mechanisms, and literature review.
     Cardiol Young. 2023;33:2452-2460.
     PubMed    
     Abstract available
     
     

131. AVITABILE CM, Yung D, Handler S, Hopper RK, et al
     Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension.
     J Pediatr. 2023 Jul 28:113639. doi: 10.1016/j.jpeds.2023.113639.
     PubMed    
     Abstract available
     
     

132. JEON K, Yoo SB, Lee Y, Lee EB, et al
     Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post-marketing surveillance.
     Pharmacoepidemiol Drug Saf. 2023;32:1387-1394.
     PubMed    
     Abstract available
     
     

133. HASSAN AB, Hozayen RF, Mustafa ZS, Lundberg IE, et al
     The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis.
     Clin Exp Rheumatol. 2023;41:2301-2311.
     PubMed    
     Abstract available
     
     

134. RADEL LJ, Iqbal M, Griffiths M
     Intravenous prostacyclins for right ventricular failure following left ventricular assist device in paediatric heart failure.
     Cardiol Young. 2023;33:2422-2424.
     PubMed    
     Abstract available
     
     

135. ZHANG YW, Wu D, Zhu ZZ, Ou JC, et al
     Analysis of the Imaging Features and Prognosis of Pulmonary Tuberculosis Complicated with Pulmonary Embolism.
     Curr Med Imaging. 2024;20:e310323215270.
     PubMed    
     Abstract available
     
     

136. YASUHARA J, Watanabe K, Watanabe A, Shirasu T, et al
     Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis.
     Cardiol Young. 2023;33:2297-2311.
     PubMed    
     Abstract available
     
     

137. NIZHNIKAVA V, Reiter U, Kovacs G, Reiter C, et al
     Myocardial strain parameters in pulmonary hypertension are determined by changes in volumetric function rather than by hemodynamic alterations.
     Eur J Radiol. 2023;170:111187.
     PubMed    
     Abstract available
     
     

138. STEINBERG ZL, Rayner SG, Leary PJ
     Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli.
     Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30919.
     PubMed    
     Abstract available
     
     

139. HUANG Y, Luo Y, Hou H, Gao J, et al
     Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.
     BMC Pulm Med. 2023;23:465.
     PubMed    
     Abstract available
     
     

140. OLIVEIRA APS, Campoy AT, Oliveira RKF, Ota-Arakaki JS, et al
     Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil.
     J Bras Pneumol. 2023;49:e20230020.
     PubMed    
     
     
     

141. WEISS T, Near AM, Zhao X, Ramey DR, et al
     Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis.
     BMC Pulm Med. 2023;23:455.
     PubMed    
     Abstract available
     
     

142. AKDOGAN A, Sari A, Sade LE
     Primary Systemic Vasculitides as a Cause of Group IV Pulmonary Hypertension.
     Anatol J Cardiol. 2023 Nov 21. doi: 10.14744/AnatolJCardiol.2023.3650.
     PubMed    
     Abstract available
     
     

143. WANG Z, Li X, Li M, Peng J, et al
     The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis.
     BMC Cardiovasc Disord. 2023;23:569.
     PubMed    
     Abstract available
     
     

144. WANG C, Yang H, Li T, Wen Y, et al
     Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis.
     Clin Respir J. 2023 Nov 20. doi: 10.1111/crj.13720.
     PubMed    
     Abstract available
     
     

145. LI N, Su S, Xie X, Yang Z, et al
     Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
     J Ethnopharmacol. 2023;320:117436.
     PubMed    
     Abstract available
     
     

146. LIU Y, Zhu L, Ming Y, Wu Z, et al
     A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification.
     J Transl Med. 2023;21:821.
     PubMed    
     Abstract available
     
     

147. DHONT S, Stassen J, Herbots L, Hoedemakers S, et al
     Exercise Pulmonary Hypertension by the mPAP/CO slope in Primary Mitral Regurgitation.
     Eur Heart J Cardiovasc Imaging. 2023 Nov 17:jead313. doi: 10.1093.
     PubMed    
     Abstract available
     
     

148. CSOSZA G, Szucs G, Rozgonyi Z, Csoma B, et al
     Circulating apelin, IL22RA2 and VEGF in pre-capillary pulmonary hypertension.
     Physiol Int. 2023 Nov 17. doi: 10.1556/2060.2023.00264.
     PubMed    
     Abstract available
     
     

149. THOMAS C, Tobes D, Trela K, Montes M, et al
     A Case Report of Percutaneous Right Ventricular Assist Device Utilization After Cesarean Delivery in a Patient With Severe Pulmonary Arterial Hypertension.
     A A Pract. 2023;17:e01728.
     PubMed    
     Abstract available
     
     

150. TSOI SM, Nawaytou H, Almeneisi H, Steurer M, et al
     Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
     Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26759.
     PubMed    
     Abstract available
     
     

151. VAIDY A, O'Corragain O, Vaidya A
     Diagnosis and Management of Pulmonary Hypertension and Right Ventricular Failure in the Cardiovascular Intensive Care Unit.
     Crit Care Clin. 2024;40:121-135.
     PubMed    
     Abstract available
     
     

152. TANG L, Cai Q, Wang X, Li X, et al
     Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
     Clin Exp Hypertens. 2023;45:2278205.
     PubMed    
     Abstract available
     
     

153. MILARA J, Roger I, Montero P, Artigues E, et al
     Targeting IL-11 system as a treatment of pulmonary arterial hypertension.
     Pharmacol Res. 2023;197:106985.
     PubMed    
     Abstract available
     
     

154. YI Y, Tianxin Y, Zhangchi L, Cui Z, et al
     Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
     Eur J Pharmacol. 2023;960:176169.
     PubMed    
     Abstract available
     
     

155. GERZEN OP, Lisin RV, Balakin AA, Mukhlynina EA, et al
     Characteristics of the right atrial and right ventricular contractility in a model of monocrotaline-induced pulmonary arterial hypertension.
     J Muscle Res Cell Motil. 2023;44:299-309.
     PubMed    
     Abstract available
     
     

156. ALWAN L, Tomii D, Heg D, Okuno T, et al
     Impact of right ventricular-pulmonary arterial coupling on clinical outcomes in patients undergoing transcatheter aortic valve implantation.
     Cardiovasc Revasc Med. 2023;56:27-34.
     PubMed    
     Abstract available
     
     

157. SKOWRONSKI J, Keen S, Harinstein ME
     Advancing the Understanding of the Utility of Inhaled Nitric Oxide to Guide Treatment in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension.
     Am J Cardiol. 2023 Oct 25:S0002-9149(23)01138.
     PubMed    
     
     
     

158. ROSSI R, Coppi F, Sgura FA, Monopoli DE, et al
     Effects of Ivabradine on Right Ventricular Systolic Function in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale.
     Am J Cardiol. 2023;207:179-183.
     PubMed    
     Abstract available
     
     

159. TADURU SS, Roy SD
     Pericardiocentesis in Pulmonary Hypertension: Unveiling Risks and Outcomes in a National Cohort.
     Am J Cardiol. 2023 Nov 9:S0002-9149(23)01305.
     PubMed    
     
     
     

160. KAILAS M, Layton AM, Pesce M, Liberman L, et al
     Exercise-Induced Electrocardiography Changes in Pulmonary Arterial Hypertension.
     Am J Cardiol. 2023;208:60-64.
     PubMed    
     Abstract available
     
     

161. ASLANGER E, Akaslan D, Atas H, Yildirimturk O, et al
     Is Pulmonary Capillary Wedge Pressure a Reliable Indicator of Postcapillary Pulmonary Hypertension?
     Am J Cardiol. 2023 Nov 18:S0002-9149(23)01324.
     PubMed    
     Abstract available
     
     

162. TOBITA K, Sakamoto H, Inami T, Fujisawa D, et al
     Understanding Patient Perspectives Toward Shared Decision Making in Patients with Pulmonary Hypertension.
     Am J Cardiol. 2023 Nov 18:S0002-9149(23)01336.
     PubMed    
     Abstract available
     
     

163. SIMPSON CE, Ambade AS, Harlan R, Roux A, et al
     Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2023;325:L617-L627.
     PubMed    
     Abstract available
     
     

164. SELF A, Afshar K, Kafi A, Yung G, et al
     An Unexpected Cause of Lung Disease Identified After Lung Transplantation.
     Chest. 2023;164:e111-e115.
     PubMed    
     Abstract available
     
     

165. DAI Z, Thorp EB
     New Way to Study Pulmonary Hypertension in HFpEF.
     Circ Res. 2023;133:899-901.
     PubMed    
     
     
     

166. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
     Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
     Circ Res. 2023;133:885-898.
     PubMed    
     Abstract available
     
     

167. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
     A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
     Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
     PubMed    
     
     
     

168. HUMBERT M
     Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
     Eur Respir J. 2023;62:2301726.
     PubMed    
     
     
     

169. NEPTUNE ER, Cardoso WV
     Unravelling the expanding role of FGF10 signalling in lung homeostasis and maintenance.
     Eur Respir J. 2023;62:2301691.
     PubMed    
     
     
     

170. JAVAHERI S, Somers VK
     Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
     J Am Coll Cardiol. 2023;82:2006-2008.
     PubMed    
     
     
     

171. MATHIAS W JR, Le Bihan DCS, Hajjar LA
     Stress Echocardiography: Another Hilltop, and It Is Better Than Ever.
     J Am Coll Cardiol. 2023;82:1986-1988.
     PubMed    
     
     
     

172. GARGANI L, Pugliese NR, De Biase N, Mazzola M, et al
     Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation.
     J Am Coll Cardiol. 2023;82:1973-1985.
     PubMed    
     Abstract available
     
     

173. CHOI C, Banks D
     Chronic Thromboembolic Pulmonary Hypertension Due to a Rare Anterior Mediastinal Venous Malformation.
     J Cardiothorac Vasc Anesth. 2023 Aug 1:S1053-0770(23)00507.
     PubMed    
     
     
     

174. UKITA R, Patel YJ, Kelly Wu W, Francois SA, et al
     Ambulatory Seven-Day Mechanical Circulatory Support in Sheep Model of Pulmonary Hypertension and Right Heart Failure.
     J Heart Lung Transplant. 2023 Oct 29:S1053-2498(23)02081.
     PubMed    
     Abstract available
     
     

175. NATHAN SD, Chandel A, Wang Y, Xu J, et al
     Derivation and validation of a non-invasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.
     J Heart Lung Transplant. 2023 Nov 16:S1053-2498(23)02123.
     PubMed    
     Abstract available
     
     

176. FIKE CD, Aschner JL, Avachat C, Birnbaum AK, et al
     Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
     J Perinatol. 2023 Oct 31. doi: 10.1038/s41372-023-01809.
     PubMed    
     Abstract available
     
     

177. ASTASHCHANKA A, Kerr KM, Yang JZ, Bautista A, et al
     Repeat pulmonary thromboendarterectomy outcomes: A 15-year single-center retrospective review.
     J Thorac Cardiovasc Surg. 2023;166:1512-1519.
     PubMed    
     Abstract available
     
     

178. SHARMA S, Ruiz J, Paghdar S, Desai S, et al
     Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
     Transplant Proc. 2023 Nov 16:S0041-1345(23)00650.
     PubMed    
     Abstract available